Ambar Protein Industries Intrinsic Value
AMBARPIL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹168.00 | ₹134.40 - ₹201.60 | -26.6% | EPS: ₹14.00, Sector P/E: 12x |
| Book Value Method | asset | ₹58.33 | ₹52.50 - ₹64.16 | -74.5% | Book Value/Share: ₹58.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹457.90 | ₹412.11 - ₹503.69 | +100.0% | Revenue/Share: ₹781.67, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹140.00 | ₹126.00 - ₹154.00 | -38.9% | EBITDA: ₹14.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹91.58 | ₹73.26 - ₹109.90 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹178.87 | ₹160.98 - ₹196.76 | -21.9% | EPS Growth: 16.0%, Fair P/E: 12.8x |
| Growth Adjusted P/E | growth | ₹116.69 | ₹105.02 - ₹128.36 | -49.0% | Revenue Growth: 8.4%, Adj P/E: 8.3x |
| ROE Based Valuation | profitability | ₹213.33 | ₹192.00 - ₹234.66 | -6.8% | ROE: 22.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹116.67 | ₹105.00 - ₹128.34 | -49.0% | EPS: ₹14.00, BVPS: ₹58.33 |
Want to compare with current market value? Check AMBARPIL share price latest .
Valuation Comparison Chart
AMBARPIL Intrinsic Value Analysis
What is the intrinsic value of AMBARPIL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Ambar Protein Industries (AMBARPIL) is ₹140.00 (median value). With the current market price of ₹228.95, this represents a -38.9% variance from our estimated fair value.
The valuation range spans from ₹58.33 to ₹457.90, indicating ₹58.33 - ₹457.90.
Is AMBARPIL undervalued or overvalued?
Based on our multi-method analysis, Ambar Protein Industries (AMBARPIL) appears to be trading above calculated value by approximately 38.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 16.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.03 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 22.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 3.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 6.61x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Ambar Protein Industries
Additional stock information and data for AMBARPIL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹7 Cr | ₹7 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹6 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-3 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |